Page 8 - மருந்துகள் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்துகள் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்துகள் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Nifty, Sensex on continued uptrend– Tuesday closing report


Nifty, Sensex on continued uptrend– Tuesday closing report
Moneylife Digital Team
 0
We had mentioned in Monday’s closing report that Nifty, Sensex were trending up. On Tuesday, the indices opened higher but ended flat. On the NSE, there were 728 advances, 1,245 declines and 57 unchanged
 
 
 
Bajaj Auto reported domestic sales of 60,830 units in May 2021 against 40,074 units in May 2020. Total two-wheeler sales were at 2.40 lakh units against 1.13 lakh units in the year-ago period. Exports were 2.11 lakh units against 87,054 units in May 2020.
 
TVS Motor Company closed May 2021 selling 166,889 units up from 58,906 units sold in May 2020.
 
 
Glenmark Pharmaceuticals Limited announced the launch of Rufinamide tablets, 200 mg and 400 mg, a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc. ....

Uttar Pradesh , Narayana Hrudayalaya , Radico Khaitan , Grupa Company , Mutual Fund , Eisai Inc , Glenmark Pharmaceuticals , Moneylife Digital Team , Bajaj Auto , Suzlon Group , Motor Company , Suzuki India , Pharmaceuticals Limited , Info Global , Mutual Fund Returns , Ank Fixed Deposits , Nvestor Returns , Ortfolio Allocation , உத்தர் பிரதேஷ் , நாராயணா ருதாயலய , ரேடிகோ கைதன் , ரூபா நிறுவனம் , பரஸ்பர நிதி , ேசை இன்க் , க்ளேண்மர்க் மருந்துகள் , பஜாஜ் ஆட்டோ ,

Telix to Present at the 2021 Jefferies Virtual Healthcare


About
Telix Pharmaceuticals Limited
Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX). For more information visit www.telixpharma.com and follow Telix on Twitter (@TelixPharma) and LinkedIn.
Telix’s lead investigational product, Illuccix
® (TLX591-CDx) for prostate cancer imaging, has been accepted for filing by the U.S. FDA, ....

United States , Stewart Holmstrom , Christian Behrenbruch , Telix Pharmaceuticals , Telix Corporate Communications , Australian Securities Exchange , Australian Therapeutic Goods Administration , European Union , Corporate Communications , Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Chief Executive Officer , Jefferies Virtual Healthcare Conference , Molecularly Targeted Radiation , Australian Stock Exchange Tlx Ax , Telix Pharmaceuticals Limited , Christian Behrenbruch , Efferies Healthcare 2021 , Telix Pharmaceuticals , New York , ஒன்றுபட்டது மாநிலங்களில் , ஆஸ்திரேலிய பத்திரங்கள் பரிமாற்றம் , ஐரோப்பிய தொழிற்சங்கம் , பெருநிறுவன தகவல்தொடர்புகள் , மருந்துகள் வரையறுக்கப்பட்டவை , தலைமை நிர்வாகி அதிகாரி ,